MOR Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $18.04 = $180.4
MOR Charts
MOR Prices
View the MOR historical prices.
52WL $4.19
The 52 Week Low is $4.19 set on Wed, Mar 15, 2023.
52WH $18.31
The 52 Week High is $18.31 set on Mon, Mar 4, 2024. The current price, $18.04, is 0% below the 52 Week High.
ATH $37.74
The All-Time High is $37.74 set on Thu, Jan 9, 2020. The current price, $18.04, is 0% below the All Time High.
52 Week Range
MOR Dividends
MOR has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
MOR Profile
MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma.
